Research Program in Systems Oncology, University of Helsinki, Helsinki, Finland.
Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland.
Nat Commun. 2022 Feb 11;13(1):835. doi: 10.1038/s41467-022-28389-3.
The majority of high-grade serous ovarian cancers (HGSCs) are deficient in homologous recombination (HR) DNA repair, most commonly due to mutations or hypermethylation of the BRCA1/2 genes. We aimed to discover how BRCA1/2 mutations shape the cellular phenotypes and spatial interactions of the tumor microenvironment. Using a highly multiplex immunofluorescence and image analysis we generate spatial proteomic data for 21 markers in 124,623 single cells from 112 tumor cores originating from 31 tumors with BRCA1/2 mutation (BRCA1/2mut), and from 13 tumors without alterations in HR genes. We identify a phenotypically distinct tumor microenvironment in the BRCA1/2mut tumors with evidence of increased immunosurveillance. Importantly, we report a prognostic role of a proliferative tumor-cell subpopulation, which associates with enhanced spatial tumor-immune interactions by CD8+ and CD4 + T-cells in the BRCA1/2mut tumors. The single-cell spatial landscapes indicate distinct patterns of spatial immunosurveillance with the potential to improve immunotherapeutic strategies and patient stratification in HGSC.
大多数高级别浆液性卵巢癌(HGSCs)存在同源重组(HR)DNA 修复缺陷,最常见的原因是 BRCA1/2 基因的突变或甲基化。我们旨在探索 BRCA1/2 突变如何塑造肿瘤微环境的细胞表型和空间相互作用。我们使用高度多重免疫荧光和图像分析,为源自 31 个带有 BRCA1/2 突变(BRCA1/2mut)的肿瘤和 13 个 HR 基因无改变的肿瘤的 112 个肿瘤核心中的 124623 个单个细胞中的 21 个标记生成空间蛋白质组学数据。我们在 BRCA1/2mut 肿瘤中发现了一种表型上明显不同的肿瘤微环境,表明免疫监视增加。重要的是,我们报告了一个增殖性肿瘤细胞亚群的预后作用,该亚群与 BRCA1/2mut 肿瘤中 CD8+和 CD4+T 细胞增强的空间肿瘤免疫相互作用相关。单细胞空间景观表明存在独特的空间免疫监视模式,有可能改善 HGSC 的免疫治疗策略和患者分层。